Diagnosing a Heart Attack at 10,000 Meters

CardioSecurA passenger suddenly has chest pain on board. The crew asks for a doctor; when present, this is not always a cardiologist. The pilot has to decide if a flight diversion is required or not. The dilemma: Despite having a doctor on board, crucial ECG information is missing. As more and more older people fly and the trend towards long-distance travel increases, medical emergencies on board become more common. Particularly critical are cardiovascular complaints, as a quick and targeted treatment is crucial for the survival of the passenger. At Lufthansa, the mobile ECG system CardioSecur has been used since January 2018 and enables an unprecedented infarct diagnosis in the air.

As the world's first airline, Lufthansa equipped all A380 aircraft in its fleet with the mobile ECG CardioSecur this year. The handy, 50g lightweight system complements the previous on board medical care in an initial oneyear pilot phase and forms an important interface between the crew in the aircraft and medical advice on the ground.

The intuitive system allows the cabin crew, without any cardiology expertise, to record a passenger's ECG and send it directly to International SOS, the medical hotline, for diagnosis. Dr. med. Sven-Karsten Peters, internal cardiologist for Lufthansa’s medical services is thrilled. He sees outstanding advantages in the intuitive use, the seamless integration into existing processes, and the high data quality in emergency situations on board: "Because the severity of the symptoms does not necessarily provide information about the severity of the illness, it is difficult not only for the crew, but also for the doctors on the ground, to assess whether an unscheduled landing for medical treatment is required. CardioSecur's in-depth 12-lead ECG data - straight from the plane - is a true innovation, giving physicians a much more detailed basis for decisionmaking." CardioSecur's ECG data was used on average twice per month on 14 aircrafts. The ECG interpretation from ISOS triggered the right decision with regard to necessary alternative landings every time.

For more information on the mobile ECG system, please visit:
http://www.cardiosecur.com
http://www.mobile-ecg.com

About Personal MedSystems GmbH

Personal MedSystems GmbH develops and distributes mobile ECG systems and services for private users and healthcare professionals under the name CardioSecur. CardioSecur Active is an innovative 15-lead, clinical-grade ECG for home use. In just a few seconds, it generates individualized feedback on changes in the heart health and provides a simple recommendation on whether to visit a doctor or not. The entire system consists of a 50 gram light cable with only four electrodes, the free CardioSecur Active App and the user's smartphone or tablet. CardioSecur Pro is the mobile, clinical ECG solution for physicians and healthcare professionals, as well as enterprise clients. CardioSecur Pro provides with 22 leads a 360 ° view of the heart and thereby is the only system that meets the cardiology guidelines of Europe, scrutinizing the anterior, lateral, inferior and posterior wall of the heart for infarcts.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...